2024
Cerebral embolic protection device utilization and outcomes in transcatheter aortic valve replacement: A nationally representative propensity matched analysis
Altibi A, Alhuneafat L, Jabri A, Al-Abdouh A, Ghanem F. Cerebral embolic protection device utilization and outcomes in transcatheter aortic valve replacement: A nationally representative propensity matched analysis. Cardiovascular Revascularization Medicine 2024, 67: 112-114. PMID: 38653674, DOI: 10.1016/j.carrev.2024.04.003.Peer-Reviewed Original ResearchTranscatheter aortic valve replacementCerebral embolic protection devicesAortic valve replacementPropensity score matchingNational Readmission DatabaseIn-hospital strokeValve replacementIn-hospitalPeriprocedural strokeOdds ratioTranscatheter aortic valve replacement patientsTransfemoral transcatheter aortic valve replacementPropensity score matched cohortAssociated with decreased riskScore matchingPropensity matched analysisRisk of periprocedural strokeRisk of in-hospital strokeAcute kidney injuryTAVR admissionsIn-hospital mortalityConfidence intervalsOutcomes post-TAVRAssociated with reduced oddsEmbolic protection devices
2022
Clinical Outcomes of Revascularization with Percutaneous Coronary Intervention Prior to Transcatheter Aortic Valve Replacement: A Comprehensive Meta-Analysis
Altibi A, Ghanem F, Hammad F, Patel J, Song H, Golwala H, Zahr F, Rahmouni H. Clinical Outcomes of Revascularization with Percutaneous Coronary Intervention Prior to Transcatheter Aortic Valve Replacement: A Comprehensive Meta-Analysis. Current Problems In Cardiology 2022, 47: 101339. PMID: 35908687, DOI: 10.1016/j.cpcardiol.2022.101339.Peer-Reviewed Original ResearchConceptsTranscatheter aortic valve replacementCoexisting coronary artery diseaseIncreased risk of life-threatening bleedingCoronary artery diseaseRisk of life-threatening bleedingLife-threatening bleedingAortic valve replacementOutcomes of revascularizationValve replacementIncreased riskOdds ratioTranscatheter aortic valve replacement patientsSignificant coronary artery diseasePooled estimates of odds ratiosMeta-analysisAcute kidney injuryEstimates of odds ratiosAssociated with improved 30-dayPercutaneous coronary interventionRandom-effects modelNo significant differencePacemaker implantationPost-TAVRKidney injuryClinical outcomes